Gaxos.AI 3Q 2026: Revenue $2.81M, EPS ($0.08) — 10-Q Summary
Gaxos.AI reported 3Q 2026 revenue of $2.81M, up 465% YoY, with net loss narrowing 7.2% YoY. Growth came from RNK Health and subscriptions, while increased marketing costs offset operating loss improvements. Diluted EPS was ($0.08).
How this was made

The 30-second read
Why it matters
The 10‑Q filing provides the first detailed financial snapshot, showing rapid top‑line growth but still significant losses.
Market read
Micro‑cap earnings with strong revenue growth may prompt short‑term trading interest, though overall market impact is limited.
What to watch
Dependence on RNK Health contract and the recent divestiture of gaming assets could affect future revenue streams.
Background
Gaxos.AI is a small AI‑services company that recently sold most of its gaming assets and is shifting focus to health‑tech administrative services and subscription software.
Ticker impact
Gaxos.AI reported Q3 2026 revenue of $2.81M, a 465% YoY increase, and a narrowed net loss, marking its first public 10‑Q disclosure of these figures.
potential modest upside as the market prices in the improved loss profile
Micro‑cap earnings often trigger short‑term moves; the magnitude of the numbers is small, so impact is likely limited.
Market effects
Highlights growth potential in niche AI‑services and subscription models for health‑tech firms.
Limited to U.S. micro‑cap investors; no broader regional effect.
Minimal global relevance beyond niche AI sector observers.
Counterpoint
The revenue surge may be unsustainable; high marketing spend could erode future profitability.
Key entities
- partnerRNK Health
Provides administrative‑services revenue of $2.0M to Gaxos.AI.


